)
Dmitry Gumerov
Senior Director, CMC, Pharmaceutical Sciences and Technology,
Visterra Inc. (Otsuka company)
Dmitry R. Gumerov is a highly experienced professional in Pharmaceutical Sciences and Technology (CMC), with over 15 years’ expertise in biologics and small molecule product development. He excels in leading technology transfers, regulatory compliance with standards like USP, Ph. Eur., and JP, and delivering successful INDs and BLAs. Currently the Senior Director of Pharmaceutical Sciences and Technology at Visterra/Otsuka, he manages analytical development and QC, as well as partnered manufacturing activities. His previous tenure at Mersana Therapeutics included building an analytical group and advancing multiple ADC programs. He holds patents and is renowned for technical leadership, regulatory acumen, and collaborative execution.